Katherine A. High
University of Pennsylvania, Children’s Hospital of Philadelphia, and Rockefeller University
2026 Breakthrough Prize in Life Sciences
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.